
Bonitas, Medscheme clash over scope of CMS investigation
Medscheme says the CMS has broadened its investigation into Bonitas’s procurement processes, but Bonitas disputes that interpretation.

Medscheme says the CMS has broadened its investigation into Bonitas’s procurement processes, but Bonitas disputes that interpretation.

The regulator says it is monitoring the situation and sees signs of improvement, but some members continue to report difficulties accessing healthcare and resolving claims.

Medscheme says it repeatedly warned Bonitas against a ‘clean-cut’ transition and disputes the scheme’s claim that unresolved legacy issues were behind the service disruptions experienced by members after the administration switch.

The medical scheme says legacy issues contributed to post-transition challenges as members report delays with hospital authorisations and medication approvals.

Broad-based earnings growth was accompanied by tighter new business margins as the group contended with product-mix pressure across parts of the business.

The scheme says continuity of care remains the priority as it moves administration to Momentum Health and managed care to PHA on 1 June.

From broker commissions to digital channels and claims processing, Momentum Health has set out what stakeholders can expect when Bonitas changes administrators.

Private Health Administrators outlines how provider contracts, managed-care operations, and service commitments will work from 1 June.

The appointment strengthens Medscheme’s foothold in the employer-based healthcare sector.

Sanlam and Momentum outline how they are managing workforce, operations, and risk as the Bonitas transition proceeds despite an unresolved court challenge.

Medscheme’s bid to halt Bonitas’ administration transition has been delayed after procedural lapses and unresolved interlocutory issues forced the matter off the urgent roll.

Bonitas, Medscheme, and PHA trade accusations as court papers, whistleblower claims, and a CMS probe intensify the battle over medical scheme contracts.

The scheme and the regulator say a narrowly focused investigation will not halt the transition – but members should brace for some operational changes.

Bonitas’ decision to change administrators comes amid a CMS investigation and High Court proceedings involving its former service provider.

Momentum Health is proposing to raise contributions by an average of 9.9% in 2026 – the highest increase among the five largest open schemes.

Downgrading to a lower plan may appear to be a cost-saving strategy, but it frequently results in increased out-of-pocket expenses.

The Council for Medical Schemes has advised medical schemes to limit their contribution increases for 2025 to 4.4% plus ‘reasonable’ utilisation estimates.